Somewhat Positive Media Coverage Somewhat Unlikely to Impact Midatech Pharma PLC (MTP) Stock Price
Headlines about Midatech Pharma PLC (NASDAQ:MTP) have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Midatech Pharma PLC earned a news impact score of 0.03 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.2297263550377 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Midatech Pharma PLC (NASDAQ MTP) traded up 6.20% during mid-day trading on Friday, hitting $2.57. The stock had a trading volume of 50,011 shares. The firm’s market cap is $62.60 million. The stock has a 50 day moving average of $2.62 and a 200-day moving average of $2.75. Midatech Pharma PLC has a 1-year low of $2.25 and a 1-year high of $4.42.
COPYRIGHT VIOLATION WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Midatech Pharma PLC (MTP) Stock Price” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/08/20/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-midatech-pharma-plc-mtp-stock-price.html.
Midatech Pharma PLC Company Profile
Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company’s segments include Pipeline Research and Development, and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms.
Receive News & Stock Ratings for Midatech Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midatech Pharma PLC and related stocks with our FREE daily email newsletter.